The Association of Indian Medical Device Industry (AiMeD) has welcomed Haryana’s newly announced Pharmaceutical and Medical Devices Manufacturing Policy 2026, describing it as a transformative initiative that could accelerate the growth of India’s healthcare manufacturing sector.
The state government aims to attract more than INR 10,000 crore in investments over the next five years through the policy. It is also expected to create around 20,000 jobs across the pharmaceutical and medical device industries.
According to AiMeD, the policy stands out for its strong financial support mechanisms. Manufacturers can avail capital expenditure (CAPEX) incentives of up to 30 percent and operational expenditure (OPEX) incentives of up to 80 percent. The benefits are capped at INR 200 crore for CAPEX and INR 20 crore for OPEX.
Beyond financial assistance, the policy offers a range of measures designed to strengthen the sector. These include incentives linked to exports, support for patent commercialization, encouragement for research and development activities, promotion of environmentally sustainable manufacturing practices, and streamlined regulatory approval processes.
Reacting to the announcement, Rajiv Nath, Forum Coordinator, AiMeD, said, “We wholeheartedly applaud Haryana’s visionary policy. It is the most incentivising framework from any progressive state, combining attractive and highly flexible CAPEX and OPEX incentives with strong support for innovation, sustainability, and exports.”
The initiative has also received support from Pawan Choudhary, Advisor to the Chief Minister of Haryana for the Foreign Cooperation Department. He emphasized the state’s focus on creating a business-friendly investment environment.
“Haryana transforms investor interest into real opportunities. As a trusted partner for long-term economic growth, its landmark policy couples generous CAPEX and OPEX incentives with a transparent single-window system.”
“This clarity assures ease of doing business, accelerates overseas investment, and positions Haryana as a preferred global destination for medical device manufacturing,” he added.
Industry stakeholders believe the policy’s combination of financial incentives, infrastructure development, innovation support, and simplified regulations will help strengthen India’s pharmaceutical and medical device manufacturing ecosystem while attracting both domestic and global investors.
With its ambitious investment targets and industry-focused incentives, Haryana’s Pharmaceutical and Medical Devices Manufacturing Policy 2026 has the potential to emerge as a benchmark for other states. The initiative is expected to boost manufacturing capacity, encourage innovation, and further strengthen India’s position in the global healthcare manufacturing landscape.
(Logo courtesy: aimedindia.com)